The CarisTouch is a state-of-the-art All-In-One designed for healthcare. Its enclosure contains anti-microbial additive and the screen is built to protect against liquid sprays. Embedding the optional privacy HIPAA filter eliminates the possibility of scratches. -15", 17", 21.5" - Projected Capacitive or Resistive Touchscreens - Anti-microbial, spill proof bezel, True Flat or traditional - Atom DualCore 2.13GHz to i7 - Windows 7, Windows 8.1, POS Ready, Linux - Gigabit network (
Wireless option) - 4 Serial, 6 USB Ports, 2nd VGA Port (Supports Dual View) - Desktop or VESA 75 - 3 Year Warranty (On-Site Service Available)
17CT, ATOM, 2GB, SSD, WIN7, WALL, BLKPROV 17”CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17"CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17 CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17 CT, ATOM, 2GB, SSD, WIN7, WALL, BLKPROV CT All-In-One Touchcomputer (Atom, 2GB, SSD, WIN7, Wall, BLK, PROV) 17" Caristouch, Atom DC/2.13**Provinet**2GB, SSD, WIN7, Privacy, Black, Wall Mount 17" Caristouch, Atom DC'2.13**Provinet**2GB, SSD, WIN7, Privacy, Black, Wall Mount
Manufacturer: | PioneerPOS |
MSRP (CAD): | $4,251.14 *** Please contact us for corporate pricing or login to see web pricing or US$ pricing. |
Manufacturer Part: | QC9-GD2XYR-Z1 (QC9GD2XYRZ1) |
Alternate Part: | PIN-QC9GD2XYRZ1 (PINQC9GD2XYRZ1) |
Description: | 17CT, ATOM, 2GB, SSD, WIN7, WALL, BLKPROV 17”CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17"CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17 CT, ATOM, 2GB, SSD, WIN7, WALL, BLK**PROV** 17 CT, ATOM, 2GB, SSD, WIN7, WALL, BLKPROV CT All-In-One Touchcomputer (Atom, 2GB, SSD, WIN7, Wall, BLK, PROV) 17" Caristouch, Atom DC/2.13**Provinet**2GB, SSD, WIN7, Privacy, Black, Wall Mount 17" Caristouch, Atom DC'2.13**Provinet**2GB, SSD, WIN7, Privacy, Black, Wall Mount (Pioneer CarisTouch Healthcare Terminals) |
Alternates: | PIN-QC9GD2XYRZ1 17" Caristouch, Atom DC/2.13**Provinet**2GB, SSD, WIN7, Privacy, Black, Wall Mount
|
Weight: | 20Lbs (9Kgs) |
Document: | QC9-GD2XYR-Z1 Documentation |
Date Updated: | Mar 9, 2020 |